Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

Mohammad Ariful Islam; Yingjie Xu; Wei Tao; Jessalyn M Ubellacker; Michael Lim; Daniel Aum; Gha Young Lee; Kun Zhou; Harshal Zope; Mikyung Yu; Wuji Cao; James Trevor Oswald; Meshkat Dinarvand; Morteza Mahmoudi; Robert Langer; Philip W Kantoff; Omid C Farokhzad; Bruce R Zetter; Jinjun Shi

doi:10.1038/s41551-018-0331-x

Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

Nat Biomed Eng. 2018 Dec;2(12):968. doi: 10.1038/s41551-018-0331-x.

Authors

Mohammad Ariful Islam^{1

2}, Yingjie Xu³, Wei Tao¹, Jessalyn M Ubellacker^{4

5}, Michael Lim^{1

6}, Daniel Aum¹, Gha Young Lee¹, Kun Zhou³, Harshal Zope¹, Mikyung Yu¹, Wuji Cao^{1

6}, James Trevor Oswald^{1

6}, Meshkat Dinarvand¹, Morteza Mahmoudi¹, Robert Langer^{7

8}, Philip W Kantoff⁹, Omid C Farokhzad^{10

11}, Bruce R Zetter¹², Jinjun Shi¹³

Affiliations

¹ Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Oncology Division, Immunomic Therapeutics, Inc., Rockville, MD, USA.
³ Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
⁴ Hematology Division, Brigham and Women's Hospital, Boston, MA, USA.
⁵ Department of Medicine, Harvard Medical School, Boston, MA, USA.
⁶ Nanotechnology Engineering Program, University of Waterloo, Waterloo, Ontario, Canada.
⁷ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁸ Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁰ Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ofarokhzad@bwh.harvard.edu.
¹¹ King Abdulaziz University, Jeddah, Saudi Arabia. ofarokhzad@bwh.harvard.edu.
¹² Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. bruce.zetter@childrens.harvard.edu.
¹³ Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jshi@bwh.harvard.edu.

PMID: 31015729
DOI: 10.1038/s41551-018-0331-x

Abstract

The authors wish to add the following sentence into the 'Competing interests' section of this Article: "P.W.K. has investment interest in Context Therapeutics LLC, DRGT, Placon, Seer Biosciences and Tarveda Therapeutics, is a company board member for Context Therapeutics LLC, is a consultant and scientific advisory board member for BIND Biosciences, Inc., BN Immunotherapeutics, DRGT, GE Healthcare, Janssen, Metamark, New England Research Institutes, Inc., OncoCellMDX, Progenity, Sanofi, Seer Biosciences, Tarveda Therapeutics and Thermo Fisher, and serves on data safety monitoring boards for Genentech/Roche and Merck." This has now been included.

Publication types

Published Erratum